Recent Analyst Stock Rating News
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.B of A Securities Analyst
Jason Gerberry is an analyst at B of A Securities. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 12/15/2025
| Buy Now | Get Alert | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 12/15/2025 | PFE | Buy Now | Pfizer | $26.32 | 6.37% | $29 → $28 | Maintains | Neutral | Get Alert | |
| 12/09/2025 | ARWR | Buy Now | Arrowhead Pharma | $68.83 | 17.68% | $62 → $81 | Maintains | Buy | Get Alert | |
| 12/09/2025 | IONS | Buy Now | Ionis Pharmaceuticals | $80.56 | 20.4% | $86 → $97 | Maintains | Buy | Get Alert | |
| 12/09/2025 | TEVA | Buy Now | Teva Pharmaceutical Indus | $30.11 | 6.26% | $29 → $32 | Maintains | Buy | Get Alert | |
| 12/01/2025 | ARWR | Buy Now | Arrowhead Pharma | $68.83 | -9.92% | $42 → $62 | Maintains | Buy | Get Alert | |
| 11/18/2025 | JAZZ | Buy Now | Jazz Pharmaceuticals | $169.51 | 45.71% | $230 → $247 | Maintains | Buy | Get Alert | |
| 11/13/2025 | OCS | Buy Now | Oculis Holding | $20.65 | 40.47% | $30 → $29 | Maintains | Buy | Get Alert | |
| 09/23/2025 | IONS | Buy Now | Ionis Pharmaceuticals | $80.56 | 3.02% | $81 → $83 | Maintains | Buy | Get Alert | |
| 08/26/2025 | AMPH | Buy Now | Amphastar Pharma | $26.13 | 22.46% | $28 → $32 | Maintains | Neutral | Get Alert | |
| 08/12/2025 | IMVT | Buy Now | Immunovant | $26.31 | 14.03% | $33 → $30 | Maintains | Buy | Get Alert | |
| 08/12/2025 | BHVN | Buy Now | Biohaven | $11.39 | 330.17% | $50 → $49 | Maintains | Buy | Get Alert | |
| 08/05/2025 | AXSM | Buy Now | Axsome Therapeutics | $145.79 | 20.72% | $173 → $176 | Maintains | Buy | Get Alert | |
| 06/30/2025 | PROK | Buy Now | ProKidney | $2.15 | -53.38% | $3 → $1 | Downgrade | Neutral → Underperform | Get Alert | |
| 06/11/2025 | LQDA | Buy Now | Liquidia | $34.37 | -33.08% | $25 → $23 | Maintains | Buy | Get Alert | |
| 06/05/2025 | EXEL | Buy Now | Exelixis | $41.47 | 10.92% | $45 → $46 | Maintains | Neutral | Get Alert | |
| 05/08/2025 | TEVA | Buy Now | Teva Pharmaceutical Indus | $30.11 | -26.95% | $20 → $22 | Maintains | Buy | Get Alert | |
| 04/01/2025 | PCVX | Buy Now | Vaxcyte | $43.75 | 213.14% | $157 → $137 | Maintains | Buy | Get Alert | |
| 03/20/2025 | IMVT | Buy Now | Immunovant | $26.31 | 25.43% | $38 → $33 | Maintains | Buy | Get Alert | |
| 03/06/2025 | TEVA | Buy Now | Teva Pharmaceutical Indus | $30.11 | -33.59% | $23 → $20 | Maintains | Buy | Get Alert | |
| 02/28/2025 | VTRS | Buy Now | Viatris | $11.68 | -14.4% | $11 → $10 | Maintains | Underperform | Get Alert | |
| 02/11/2025 | AXSM | Buy Now | Axsome Therapeutics | $145.79 | 14.55% | $143 → $167 | Maintains | Buy | Get Alert | |
| 01/15/2025 | IMVT | Buy Now | Immunovant | $26.31 | 71.04% | $48 → $45 | Maintains | Buy | Get Alert | |
| 01/09/2025 | CPRX | Buy Now | Catalyst Pharmaceuticals | $24.03 | 24.84% | $30 → $30 | Reiterates | Buy → Buy | Get Alert | |
| 12/17/2024 | EXEL | Buy Now | Exelixis | $41.47 | -5.96% | $35 → $39 | Downgrade | Buy → Neutral | Get Alert | |
| 11/15/2024 | BLUE | Buy Now | bluebird bio | — | — | $3 → $0.5 | Downgrade | Buy → Neutral | Get Alert | |
| 11/06/2024 | ACLX | Buy Now | Arcellx | $68.92 | 45.09% | $84 → $100 | Maintains | Buy | Get Alert | |
| 10/17/2024 | ACLX | Buy Now | Arcellx | $68.92 | 21.87% | $80 → $84 | Maintains | Buy | Get Alert | |
| 10/15/2024 | EXEL | Buy Now | Exelixis | $41.47 | -22.84% | $30 → $32 | Maintains | Buy | Get Alert | |
| 09/24/2024 | BHVN | Buy Now | Biohaven | $11.39 | 444.29% | $52 → $62 | Maintains | Buy | Get Alert | |
| 09/10/2024 | RLAY | Buy Now | Relay Therapeutics | $8.20 | 192.86% | $20 → $24 | Maintains | Buy | Get Alert | |
| 09/04/2024 | PROK | Buy Now | ProKidney | $2.15 | 39.86% | $4 → $3 | Maintains | Neutral | Get Alert | |
| 09/04/2024 | PCVX | Buy Now | Vaxcyte | $43.75 | 220% | $101 → $140 | Maintains | Buy | Get Alert | |
| 08/20/2024 | LQDA | Buy Now | Liquidia | $34.37 | -33.08% | $24 → $23 | Maintains | Buy | Get Alert | |
| 08/15/2024 | BLUE | Buy Now | bluebird bio | — | — | $4 → $3 | Maintains | Buy | Get Alert | |
| 08/06/2024 | AXSM | Buy Now | Axsome Therapeutics | $145.79 | -27.29% | $95 → $106 | Upgrade | Neutral → Buy | Get Alert | |
| 07/23/2024 | IONS | Buy Now | Ionis Pharmaceuticals | $80.56 | -15.6% | $67 → $68 | Maintains | Buy | Get Alert | |
| 07/18/2024 | AXSM | Buy Now | Axsome Therapeutics | $145.79 | -34.84% | $97 → $95 | Maintains | Neutral | Get Alert | |
| 07/16/2024 | IONS | Buy Now | Ionis Pharmaceuticals | $80.56 | -16.84% | $64 → $67 | Maintains | Buy | Get Alert | |
| 06/21/2024 | PCVX | Buy Now | Vaxcyte | $43.75 | 130.86% | $101 → $101 | Reiterates | Buy → Buy | Get Alert | |
| 06/11/2024 | OCS | Buy Now | Oculis Holding | $20.65 | -3.13% | $21 → $20 | Maintains | Buy | Get Alert | |
| 05/30/2024 | TEVA | Buy Now | Teva Pharmaceutical Indus | $30.11 | -30.27% | $18 → $21 | Maintains | Buy | Get Alert | |
| 05/29/2024 | PROK | Buy Now | ProKidney | $2.15 | 86.48% | $3 → $4 | Maintains | Neutral | Get Alert | |
| 04/17/2024 | ITCI | Buy Now | Intra-Cellular Therapies | — | — | $82 → $91 | Maintains | Buy | Get Alert | |
| 04/01/2024 | GLPG | Buy Now | Galapagos | $31.28 | -0.9% | $41 → $31 | Downgrade | Neutral → Underperform | Get Alert | |
| 03/28/2024 | GLPG | Buy Now | Galapagos | $31.28 | -0.9% | $41 → $31 | Downgrade | Neutral → Underperform | Get Alert | |
| 03/25/2024 | LYRA | Buy Now | Lyra Therapeutics | $3.93 | 179.9% | $12 → $11 | Maintains | Buy | Get Alert | |
| 03/07/2024 | CPRX | Buy Now | Catalyst Pharmaceuticals | $24.03 | -4.29% | → $23 | Initiates | → Buy | Get Alert | |
| 02/06/2024 | PCVX | Buy Now | Vaxcyte | $43.75 | 110.29% | $80 → $92 | Maintains | Buy | Get Alert | |
| 01/02/2024 | ALKS | Buy Now | Alkermes | $28.03 | 3.46% | $27 → $29 | Maintains | Neutral | Get Alert | |
| 01/02/2024 | ARWR | Buy Now | Arrowhead Pharma | $68.83 | -46.24% | $29 → $37 | Maintains | Buy | Get Alert | |
| 01/02/2024 | GLPG | Buy Now | Galapagos | $31.28 | 40.66% | $41 → $44 | Maintains | Neutral | Get Alert | |
| 01/02/2024 | PCVX | Buy Now | Vaxcyte | $43.75 | 82.86% | $67 → $80 | Maintains | Buy | Get Alert | |
| 01/02/2024 | XENE | Buy Now | Xenon Pharmaceuticals | $43.84 | 27.74% | $52 → $56 | Maintains | Buy | Get Alert | |
| 01/02/2024 | PROK | Buy Now | ProKidney | $2.15 | -6.76% | $8 → $2 | Downgrade | Buy → Neutral | Get Alert | |
| 01/02/2024 | IONS | Buy Now | Ionis Pharmaceuticals | $80.56 | -23.04% | $52 → $62 | Upgrade | Neutral → Buy | Get Alert | |
| 01/02/2024 | HRMY | Buy Now | Harmony Biosciences | $39.22 | -23.51% | → $30 | Downgrade | Neutral → Underperform | Get Alert | |
| 12/21/2023 | BLUE | Buy Now | bluebird bio | — | — | $12 → $5 | Maintains | Buy | Get Alert | |
| 12/21/2023 | IMVT | Buy Now | Immunovant | $26.31 | 93.84% | $49 → $51 | Maintains | Buy | Get Alert | |
| 12/11/2023 | BLUE | Buy Now | bluebird bio | — | — | $11 → $12 | Maintains | Buy | Get Alert | |
| 12/04/2023 | ARWR | Buy Now | Arrowhead Pharma | $68.83 | -57.87% | → $29 | Initiates | → Buy | Get Alert | |
| 11/17/2023 | AMPH | Buy Now | Amphastar Pharma | $26.13 | 141.1% | → $63 | Initiates | → Neutral | Get Alert | |
| 10/26/2023 | PCVX | Buy Now | Vaxcyte | $43.75 | 380% | → $210 | Initiates | → Neutral | Get Alert | |
| 10/23/2023 | VTRS | Buy Now | Viatris | $11.68 | -22.96% | → $9 | Downgrade | Neutral → Underperform | Get Alert | |
| 10/23/2023 | IONS | Buy Now | Ionis Pharmaceuticals | $80.56 | -35.46% | $33 → $52 | Upgrade | Underperform → Neutral | Get Alert | |
| 09/12/2023 | LYRA | Buy Now | Lyra Therapeutics | $3.93 | 281.68% | $13 → $15 | Maintains | Buy | Get Alert | |
| 09/08/2023 | TEVA | Buy Now | Teva Pharmaceutical Indus | $30.11 | -56.83% | $12 → $13 | Maintains | Buy | Get Alert | |
| 09/08/2023 | KRTX | Buy Now | Karuna Therapeutics | — | — | $304 → $259 | Maintains | Buy | Get Alert | |
| 08/30/2023 | OCS | Buy Now | Oculis Holding | $20.65 | 16.25% | $23 → $24 | Maintains | Buy | Get Alert | |
| 08/10/2023 | JAZZ | Buy Now | Jazz Pharmaceuticals | $169.51 | 28.01% | $204 → $217 | Maintains | Buy | Get Alert | |
| 08/09/2023 | PCVX | Buy Now | Vaxcyte | $43.75 | 53.14% | $66 → $67 | Maintains | Buy | Get Alert | |
| 08/08/2023 | FGEN | Buy Now | FibroGen | $9.35 | -78.61% | $4 → $2 | Downgrade | Neutral → Underperform | Get Alert | |
| 08/08/2023 | AXSM | Buy Now | Axsome Therapeutics | $145.79 | -44.44% | $59 → $81 | Upgrade | Underperform → Neutral | Get Alert | |
| 07/19/2023 | BLUE | Buy Now | bluebird bio | — | — | $6 → $10 | Upgrade | Neutral → Buy | Get Alert | |
| 06/26/2023 | FGEN | Buy Now | FibroGen | $9.35 | -57.23% | $29 → $4 | Downgrade | Buy → Neutral | Get Alert | |
| 06/14/2023 | OCS | Buy Now | Oculis Holding | $20.65 | 6.56% | → $22 | Initiates | → Buy | Get Alert | |
| 05/24/2023 | LLY | Buy Now | Eli Lilly | $1.06K | -52.73% | $450 → $500 | Maintains | Buy | Get Alert | |
| 05/23/2023 | IMVT | Buy Now | Immunovant | $26.31 | 6.42% | $26 → $28 | Maintains | Buy | Get Alert | |
| 05/16/2023 | CARA | Buy Now | Cara Therapeutics | — | — | $6 → $4 | Maintains | Underperform | Get Alert | |
| 05/11/2023 | TEVA | Buy Now | Teva Pharmaceutical Indus | $30.11 | -63.47% | $13 → $11 | Maintains | Buy | Get Alert | |
| 05/10/2023 | ACLX | Buy Now | Arcellx | $68.92 | -27.46% | $39 → $50 | Maintains | Buy | Get Alert | |
| 05/01/2023 | IMVT | Buy Now | Immunovant | $26.31 | -1.18% | → $26 | Initiates | → Buy | Get Alert | |
| 04/20/2023 | HRMY | Buy Now | Harmony Biosciences | $39.22 | -10.76% | → $35 | Initiates | → Neutral | Get Alert | |
| 04/18/2023 | PCVX | Buy Now | Vaxcyte | $43.75 | 55.43% | $63 → $68 | Maintains | Buy | Get Alert | |
| 03/30/2023 | BLUE | Buy Now | bluebird bio | — | — | $8 → $6 | Maintains | Neutral | Get Alert | |
| 03/08/2023 | CARA | Buy Now | Cara Therapeutics | — | — | $13 → $6 | Downgrade | Neutral → Underperform | Get Alert | |
| 02/28/2023 | PCVX | Buy Now | Vaxcyte | $43.75 | 44% | $64 → $63 | Maintains | Buy | Get Alert | |
| 02/14/2023 | AXSM | Buy Now | Axsome Therapeutics | $145.79 | -64.33% | → $52 | Reiterates | → Underperform | Get Alert | |
| 01/05/2023 | AMTI | Buy Now | Applied Molecular | — | — | $5 → $0.5 | Downgrade | Buy → Underperform | Get Alert | |
| 01/05/2023 | FGEN | Buy Now | FibroGen | $9.35 | 188.72% | $18 → $27 | Upgrade | Neutral → Buy | Get Alert | |
| 12/13/2022 | ACLX | Buy Now | Arcellx | $68.92 | -46.32% | → $37 | Reinstates | → Buy | Get Alert | |
| 12/12/2022 | ALLO | Buy Now | Allogene Therapeutics | $1.47 | 514.33% | → $9 | Downgrade | Buy → Underperform | Get Alert | |
| 10/14/2022 | ALKS | Buy Now | Alkermes | $28.03 | -10.81% | $27 → $25 | Upgrade | Underperform → Neutral | Get Alert | |
| 10/14/2022 | OGN | Buy Now | Organon | $7.24 | 245.54% | $37 → $25 | Downgrade | Neutral → Underperform | Get Alert | |
| 08/29/2022 | XENE | Buy Now | Xenon Pharmaceuticals | $43.84 | — | — | Initiates | → Buy | Get Alert | |
| 08/09/2022 | KRTX | Buy Now | Karuna Therapeutics | — | — | $160 → $261 | Maintains | Buy | Get Alert | |
| 08/05/2022 | TEVA | Buy Now | Teva Pharmaceutical Indus | $30.11 | -56.83% | $10 → $13 | Upgrade | Neutral → Buy | Get Alert | |
| 08/05/2022 | OGN | Buy Now | Organon | $7.24 | 411.4% | $40 → $37 | Downgrade | Buy → Neutral | Get Alert | |
| 05/17/2022 | TEVA | Buy Now | Teva Pharmaceutical Indus | $30.11 | -70.11% | → $9 | Upgrade | Underperform → Neutral | Get Alert | |
| 03/01/2022 | VTRS | Buy Now | Viatris | $11.68 | 11.28% | $21 → $13 | Downgrade | Buy → Neutral | Get Alert | |
| 03/01/2022 | ACLX | Buy Now | Arcellx | $68.92 | -65.18% | → $24 | Initiates | → Buy | Get Alert | |
| 02/01/2022 | MRTX | Buy Now | Mirati Therapeutics | — | — | $171 → $141 | Upgrade | Underperform → Neutral | Get Alert | |
| 02/01/2022 | IONS | Buy Now | Ionis Pharmaceuticals | $80.56 | -62.76% | $40 → $30 | Downgrade | Buy → Underperform | Get Alert | |
| 12/02/2021 | BYSI | Buy Now | BeyondSpring | $2.00 | 150% | $45 → $5 | Downgrade | Buy → Underperform | Get Alert | |
| 10/11/2021 | DICE | Buy Now | DICE Therapeutics | — | — | → $41 | Initiates | → Buy | Get Alert | |
| 09/02/2021 | ALKS | Buy Now | Alkermes | $28.03 | -3.67% | → $27 | Downgrade | Neutral → Underperform | Get Alert | |
| 09/01/2021 | OGN | Buy Now | Organon | $7.24 | 494.33% | → $43 | Initiates | → Buy | Get Alert | |
| 07/16/2021 | FGEN | Buy Now | FibroGen | $9.35 | 210.1% | → $29 | Downgrade | Buy → Neutral | Get Alert | |
| 04/13/2021 | FNCH | Buy Now | Finch Therapeutics Gr | $13.55 | 84.5% | → $25 | Initiates | → Buy | Get Alert | |
| 03/31/2021 | FGEN | Buy Now | FibroGen | $9.35 | 402.58% | → $47 | Upgrade | Neutral → Buy | Get Alert | |
| 03/24/2021 | BHC | Buy Now | Bausch Health Companies | $6.83 | 295.31% | → $27 | Downgrade | Neutral → Underperform | Get Alert | |
| 01/22/2021 | LLY | Buy Now | Eli Lilly | $1.06K | -78.73% | $195 → $225 | Maintains | Buy | Get Alert | |
| 01/11/2021 | BYSI | Buy Now | BeyondSpring | $2.00 | 1150% | → $25 | Initiates | → Buy | Get Alert | |
| 11/17/2020 | MRTX | Buy Now | Mirati Therapeutics | — | — | → $196 | Downgrade | Neutral → Underperform | Get Alert | |
| 11/05/2020 | BLUE | Buy Now | bluebird bio | — | — | $100 → $81 | Maintains | Buy | Get Alert | |
| 10/19/2020 | AERI | Buy Now | Aerie Pharmaceuticals | — | — | → $9 | Downgrade | Neutral → Underperform | Get Alert | |
| 09/30/2020 | ALKS | Buy Now | Alkermes | $28.03 | -32.22% | $21 → $19 | Maintains | Neutral | Get Alert | |
| 09/30/2020 | ARNA | Buy Now | Arena Pharmaceuticals | — | — | $75 → $85 | Maintains | Buy | Get Alert | |
| 09/28/2020 | MRTX | Buy Now | Mirati Therapeutics | — | — | → $172 | Initiates | → Neutral | Get Alert | |
| 09/17/2020 | BHC | Buy Now | Bausch Health Companies | $6.83 | 178.18% | $16 → $19 | Upgrade | Underperform → Neutral | Get Alert | |
| 08/21/2020 | GLPG | Buy Now | Galapagos | $31.28 | 328.39% | $148 → $134 | Maintains | Underperform | Get Alert | |
| 08/17/2020 | HZNP | Buy Now | Horizon Therapeutics | — | — | $92 → $95 | Maintains | Buy | Get Alert | |
| 07/16/2020 | CHRS | Buy Now | Coherus BioSciences | $1.35 | 1376.01% | → $20 | Initiates | → Neutral | Get Alert | |
| 07/15/2020 | VRCA | Buy Now | Verrica Pharmaceuticals | $8.04 | 24.38% | $17 → $10 | Downgrade | Buy → Neutral | Get Alert | |
| 07/13/2020 | BLUE | Buy Now | bluebird bio | — | — | $104 → $100 | Maintains | Buy | Get Alert | |
| 07/13/2020 | GBT | Buy Now | Global Blood Therapeutics | — | — | → $92 | Initiates | → Buy | Get Alert | |
| 07/07/2020 | BHC | Buy Now | Bausch Health Companies | $6.83 | 104.98% | $12 → $14 | Maintains | Underperform | Get Alert | |
| 06/30/2020 | AMTI | Buy Now | Applied Molecular | — | — | → $34 | Initiates | → Buy | Get Alert | |
| 06/19/2020 | LLY | Buy Now | Eli Lilly | $1.06K | -82.98% | $165 → $180 | Maintains | Buy | Get Alert | |
| 06/18/2020 | JAZZ | Buy Now | Jazz Pharmaceuticals | $169.51 | -1.48% | $165 → $167 | Maintains | Buy | Get Alert | |
| 05/26/2020 | HZNP | Buy Now | Horizon Therapeutics | — | — | $52 → $57 | Reiterates | → Buy | Get Alert | |
| 05/26/2020 | LYRA | Buy Now | Lyra Therapeutics | $3.93 | 434.35% | → $21 | Initiates | → Buy | Get Alert | |
| 05/18/2020 | ABBV | Buy Now | AbbVie | $227.62 | -58.26% | → $95 | Reinstates | → Neutral | Get Alert | |
| 05/08/2020 | TEVA | Buy Now | Teva Pharmaceutical Indus | $30.11 | -73.44% | $7 → $8 | Reiterates | → Underperform | Get Alert | |
| 04/27/2020 | FGEN | Buy Now | FibroGen | $9.35 | 381.2% | → $45 | Initiates | → Neutral | Get Alert | |
| 03/26/2020 | ARNA | Buy Now | Arena Pharmaceuticals | — | — | $47 → $56 | Upgrade | Neutral → Buy | Get Alert | |
| 03/23/2020 | TEVA | Buy Now | Teva Pharmaceutical Indus | $30.11 | -76.76% | $11 → $7 | Maintains | Underperform | Get Alert | |
| 03/23/2020 | JAZZ | Buy Now | Jazz Pharmaceuticals | $169.51 | -3.84% | $178 → $163 | Maintains | Buy | Get Alert | |
| 03/23/2020 | HZNP | Buy Now | Horizon Therapeutics | — | — | $45 → $42 | Maintains | Buy | Get Alert | |
| 03/23/2020 | ALKS | Buy Now | Alkermes | $28.03 | -39.35% | $20 → $17 | Maintains | Neutral | Get Alert | |
| 03/23/2020 | AERI | Buy Now | Aerie Pharmaceuticals | — | — | $26 → $17 | Maintains | Neutral | Get Alert | |
| 02/24/2020 | GLPG | Buy Now | Galapagos | $31.28 | 580.95% | → $213 | Downgrade | Neutral → Underperform | Get Alert | |
| 02/13/2020 | TEVA | Buy Now | Teva Pharmaceutical Indus | $30.11 | -63.47% | $8 → $11 | Maintains | Underperform | Get Alert | |
| 12/02/2019 | GLPG | Buy Now | Galapagos | $31.28 | 536.19% | → $199 | Initiates | → Neutral | Get Alert | |
| 11/13/2019 | ARNA | Buy Now | Arena Pharmaceuticals | — | — | → $51 | Initiates | → Neutral | Get Alert | |
| 10/17/2019 | BMY | Buy Now | Bristol-Myers Squibb | $53.83 | 11.46% | → $60 | Reinstates | → Buy | Get Alert | |
| 10/17/2019 | LLY | Buy Now | Eli Lilly | $1.06K | -87.43% | → $133 | Reinstates | → Buy | Get Alert | |
| 10/17/2019 | PFE | Buy Now | Pfizer | $26.32 | 40.56% | → $37 | Reinstates | → Neutral | Get Alert | |
| 10/17/2019 | MRK | Buy Now | Merck & Co | $100.20 | -10.18% | → $90 | Reinstates | → Neutral | Get Alert | |
| 10/10/2019 | BMY | Buy Now | Bristol-Myers Squibb | $53.83 | -7.11% | $49 → $50 | Reiterates | → Neutral | Get Alert | |
| 09/26/2019 | HZNP | Buy Now | Horizon Therapeutics | — | — | → $34 | Initiates | → Buy | Get Alert | |
| 09/10/2019 | LLY | Buy Now | Eli Lilly | $1.06K | -88.66% | $118 → $120 | Reiterates | → Neutral | Get Alert | |
| 09/03/2019 | BMY | Buy Now | Bristol-Myers Squibb | $53.83 | -8.97% | $46 → $49 | Maintains | Neutral | Get Alert | |
| 07/30/2019 | PFE | Buy Now | Pfizer | $26.32 | — | — | Downgrade | Buy → Neutral | Get Alert | |
| 05/30/2019 | TEVA | Buy Now | Teva Pharmaceutical Indus | $30.11 | -70.11% | $19 → $9 | Downgrade | Buy → Underperform | Get Alert | |
| 05/01/2019 | MRK | Buy Now | Merck & Co | $100.20 | -9.18% | $90 → $91 | Maintains | Buy | Get Alert | |
| 04/01/2019 | PFE | Buy Now | Pfizer | $26.32 | 82.35% | $45 → $48 | Maintains | Buy | Get Alert | |
| 03/20/2019 | BHC | Buy Now | Bausch Health Companies | $6.83 | 163.54% | → $18 | Reinstates | → Underperform | Get Alert | |
| 02/19/2019 | BMY | Buy Now | Bristol-Myers Squibb | $53.83 | -5.26% | $53 → $51 | Maintains | Neutral | Get Alert | |
| 01/03/2019 | ABBV | Buy Now | AbbVie | $227.62 | — | — | Downgrade | Buy → Neutral | Get Alert | |
| 01/03/2019 | TEVA | Buy Now | Teva Pharmaceutical Indus | $30.11 | — | — | Upgrade | Underperform → Buy | Get Alert | |
| 12/12/2018 | FOMX | Buy Now | Foamix Pharmaceuticals | — | — | → $11 | Initiates | → Buy | Get Alert | |
| 11/06/2018 | MYL | Buy Now | Mylan | — | — | $44 → $42 | Upgrade | Neutral → Buy | Get Alert | |
| 11/02/2018 | TEVA | Buy Now | Teva Pharmaceutical Indus | $30.11 | -33.59% | $19 → $20 | Maintains | Underperform | Get Alert | |
| 10/04/2018 | ABBV | Buy Now | AbbVie | $227.62 | -53.43% | $107 → $106 | Maintains | Buy | Get Alert | |
| 08/27/2018 | NBRV | Buy Now | Nabriva Therapeutics | — | — | $9 → $5 | Maintains | Buy | Get Alert | |
| 08/22/2018 | ABBV | Buy Now | AbbVie | $227.62 | -52.99% | $105 → $107 | Maintains | Buy | Get Alert | |
| 08/01/2018 | PFE | Buy Now | Pfizer | $26.32 | 63.35% | $42 → $43 | Maintains | Buy | Get Alert | |
| 07/30/2018 | ABBV | Buy Now | AbbVie | $227.62 | -53.87% | $112 → $105 | Maintains | Buy | Get Alert | |
| 07/30/2018 | MRK | Buy Now | Merck & Co | $100.20 | -26.15% | $70 → $74 | Maintains | Buy | Get Alert | |
| 07/27/2018 | ALKS | Buy Now | Alkermes | $28.03 | 92.65% | $56 → $54 | Maintains | Buy | Get Alert | |
| 07/25/2018 | LLY | Buy Now | Eli Lilly | $1.06K | -91.11% | $90 → $94 | Maintains | Neutral | Get Alert | |
| 07/17/2018 | LLY | Buy Now | Eli Lilly | $1.06K | -91.49% | $86 → $90 | Maintains | Neutral | Get Alert | |
| 06/12/2018 | AGN | Buy Now | Allergan | — | — | $209 → $213 | Maintains | Buy | Get Alert | |
| 05/29/2018 | MYL | Buy Now | Mylan | — | — | $43 → $42 | Maintains | Neutral | Get Alert | |
| 05/22/2018 | NBRV | Buy Now | Nabriva Therapeutics | — | — | $10 → $11 | Maintains | Buy | Get Alert | |
| 05/11/2018 | ALKS | Buy Now | Alkermes | $28.03 | 99.79% | → $56 | Initiates | → Buy | Get Alert | |
| 05/01/2018 | AGN | Buy Now | Allergan | — | — | $213 → $209 | Maintains | Buy | Get Alert | |
| 04/18/2018 | BMY | Buy Now | Bristol-Myers Squibb | $53.83 | 13.32% | $68 → $61 | Maintains | Neutral | Get Alert | |
| 04/18/2018 | MRK | Buy Now | Merck & Co | $100.20 | -30.14% | $68 → $70 | Maintains | Buy | Get Alert | |
| 04/17/2018 | BMY | Buy Now | Bristol-Myers Squibb | $53.83 | 13.32% | $68 → $61 | Maintains | Neutral | Get Alert | |
| 04/17/2018 | MRK | Buy Now | Merck & Co | $100.20 | -30.14% | $68 → $70 | Maintains | Buy | Get Alert | |
| 03/05/2018 | BMY | Buy Now | Bristol-Myers Squibb | $53.83 | 26.32% | $64 → $68 | Maintains | Neutral | Get Alert | |
| 02/20/2018 | JAZZ | Buy Now | Jazz Pharmaceuticals | $169.51 | 0.29% | $164 → $170 | Maintains | Buy | Get Alert | |
| 02/09/2018 | TEVA | Buy Now | Teva Pharmaceutical Indus | $30.11 | -46.87% | $17 → $16 | Maintains | Underperform | Get Alert | |
| 02/07/2018 | AGN | Buy Now | Allergan | — | — | $208 → $215 | Maintains | Buy | Get Alert | |
| 02/01/2018 | LLY | Buy Now | Eli Lilly | $1.06K | -91.87% | $88 → $86 | Maintains | Neutral | Get Alert | |
| 11/28/2017 | MRK | Buy Now | Merck & Co | $100.20 | -36.13% | → $64 | Reinstates | Buy → Buy | Get Alert | |
| 02/22/2017 | MNTA | Buy Now | Momenta Pharmaceuticals | — | — | — | Downgrade | Outperform → Market Perform | Get Alert | |
| 02/15/2017 | BIVV | Buy Now | Bioverativ | — | — | → $56 | Initiates | → Outperform | Get Alert | |
| 12/22/2016 | CRME | Buy Now | Cardiome Pharma Corporation - Ordinary Shares (Canada) | — | — | — | Initiates | → Outperform | Get Alert | |
| 10/13/2016 | MRK | Buy Now | Merck & Co | $100.20 | — | — | Upgrade | Neutral → Buy | Get Alert | |
| 05/04/2016 | MNTA | Buy Now | Momenta Pharmaceuticals | — | — | $21 → $18 | Maintains | Outperform | Get Alert | |
| 01/27/2016 | MRK | Buy Now | Merck & Co | $100.20 | — | — | Downgrade | Buy → Neutral | Get Alert | |
| 11/05/2015 | MNTA | Buy Now | Momenta Pharmaceuticals | — | — | $25 → $22 | Maintains | Outperform | Get Alert | |
| 10/13/2015 | MNTA | Buy Now | Momenta Pharmaceuticals | — | — | $26 → $25 | Maintains | Outperform | Get Alert | |
| 06/25/2015 | LLY | Buy Now | Eli Lilly | $1.06K | — | — | Upgrade | Neutral → Buy | Get Alert | |
| 05/04/2015 | MNTA | Buy Now | Momenta Pharmaceuticals | — | — | $24 → $25 | Maintains | Outperform | Get Alert | |
| 01/09/2015 | ABBV | Buy Now | AbbVie | $227.62 | -69.25% | → $70 | Downgrade | Buy → Neutral | Get Alert | |
| 01/09/2015 | LLY | Buy Now | Eli Lilly | $1.06K | — | — | Downgrade | Buy → Neutral | Get Alert | |
| 04/24/2014 | MRK | Buy Now | Merck & Co | $100.20 | -38.12% | $57 → $62 | Maintains | Buy | Get Alert | |
| 04/24/2014 | ABBV | Buy Now | AbbVie | $227.62 | -75.84% | $58 → $55 | Maintains | Buy | Get Alert | |
| 04/01/2014 | LLY | Buy Now | Eli Lilly | $1.06K | -93.48% | $67 → $69 | Maintains | Buy | Get Alert | |
| 02/21/2014 | ABBV | Buy Now | AbbVie | $227.62 | -74.52% | $56 → $58 | Maintains | Buy | Get Alert | |
| 12/31/2013 | ABBV | Buy Now | AbbVie | $227.62 | -75.4% | $53 → $56 | Maintains | Buy | Get Alert | |
| 05/01/2013 | AGN | Buy Now | Allergan | — | — | $120 → $110 | Maintains | Buy | Get Alert | |
| 04/26/2013 | ALKS | Buy Now | Alkermes | $28.03 | 3.46% | $24 → $29 | Downgrade | Neutral → Underperform | Get Alert | |
| 03/11/2013 | ABBV | Buy Now | AbbVie | $227.62 | -81.55% | $40 → $42 | Maintains | Buy | Get Alert | |
| 03/04/2013 | MYL | Buy Now | Mylan | — | — | $33 → $34 | Maintains | Buy | Get Alert | |
| 03/04/2013 | MRK | Buy Now | Merck & Co | $100.20 | -53.09% | → $47 | Upgrade | Neutral → Buy | Get Alert | |
| 02/25/2013 | JAZZ | Buy Now | Jazz Pharmaceuticals | $169.51 | -56.35% | → $74 | Initiates | → Buy | Get Alert | |
| 02/01/2013 | ALKS | Buy Now | Alkermes | $28.03 | -14.38% | $23 → $24 | Downgrade | Buy → Neutral | Get Alert | |
| 01/23/2013 | AGN | Buy Now | Allergan | — | — | $106 → $110 | Maintains | Buy | Get Alert | |
| 01/09/2013 | LLY | Buy Now | Eli Lilly | $1.06K | -94.33% | $57 → $60 | Maintains | Buy | Get Alert | |
| 11/26/2012 | MYL | Buy Now | Mylan | — | — | — | Initiates | → Overweight | Get Alert | |
| 10/11/2012 | LLY | Buy Now | Eli Lilly | $1.06K | -94.61% | $52 → $57 | Maintains | Buy | Get Alert | |
| 08/29/2012 | LLY | Buy Now | Eli Lilly | $1.06K | -95.08% | $46 → $52 | Maintains | Buy | Get Alert | |
| 08/24/2012 | MRK | Buy Now | Merck & Co | $100.20 | -55.09% | → $45 | Downgrade | Buy → Neutral | Get Alert | |
| 06/28/2012 | ARNA | Buy Now | Arena Pharmaceuticals | — | — | $5 → $7 | Maintains | Underperform | Get Alert | |
| 06/07/2012 | MYL | Buy Now | Mylan | — | — | $26 → $27 | Maintains | Buy | Get Alert | |
| 05/07/2012 | LLY | Buy Now | Eli Lilly & | $1.06K | -95.65% | $43 → $46 | Maintains | Buy | Get Alert | |
| 04/10/2012 | AGN | Buy Now | Allergan | — | — | $100 → $106 | Maintains | Buy | Get Alert |
A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.